Schürfeld, R.* ; Sandner, B.* ; Hoffmann, A.* ; Klöting, N. ; Baratashvili, E.* ; Nowicki, M.* ; Paeschke, S.* ; Kosacka, J.* ; Kralisch, S.* ; Bachmann, A.* ; Frille, A.* ; Dietel, A.* ; Stolzenburg, J.U.* ; Blüher, M. ; Zhang, M.Z.* ; Harris, R.C.* ; Isermann, B.* ; Stumvoll, M.* ; Tönjes, A.* ; Ebert, T.*
     
    
        
Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor.
    
    
        
    
    
        
        Front. Endocrin. 14:1152444 (2023)
    
    
    
      
      
	
	    OBJECTIVE: Acyl-CoA-binding protein (ACBP)/diazepam-binding inhibitor has lately been described as an endocrine factor affecting food intake and lipid metabolism. ACBP is dysregulated in catabolic/malnutrition states like sepsis or systemic inflammation. However, regulation of ACBP has not been investigated in conditions with impaired kidney function, so far. DESIGN/METHODS: Serum ACBP concentrations were investigated by enzyme-linked immunosorbent assay i) in a cohort of 60 individuals with kidney failure (KF) on chronic haemodialysis and compared to 60 individuals with a preserved kidney function; and ii) in a human model of acute kidney dysfunction (AKD). In addition, mACBP mRNA expression was assessed in two CKD mouse models and in two distinct groups of non-CKD mice. Further, mRNA expression of mACBP was measured in vitro in isolated, differentiated mouse adipocytes - brown and white - after exposure to the uremic agent indoxyl sulfate. RESULTS: Median [interquartile range] serum ACBP was almost 20-fold increased in KF (514.0 [339.3] µg/l) compared to subjects without KF (26.1 [39.1] µg/l) (p<0.001). eGFR was the most important, inverse predictor of circulating ACBP in multivariate analysis (standardized β=-0.839; p<0.001). Furthermore, AKD increased ACBP concentrations almost 3-fold (p<0.001). Increased ACBP levels were not caused by augmented mACBP mRNA expression in different tissues of CKD mice in vivo or in indoxyl sulfate-treated adipocytes in vitro. CONCLUSIONS: Circulating ACBP inversely associates with renal function, most likely through renal retention of the cytokine. Future studies need to investigate ACBP physiology in malnutrition-related disease states, such as CKD, and to adjust for markers of renal function.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Acyl-coa-binding Protein ; Adipokines ; Chronic Kidney Disease ; Diabetic Kidney Disease ; Diazepam Binding Inhibitor ; Hemodialysis ; Type 2 Diabetes Mellitus; Kidney-disease; Interleukin-6; Progranulin; Expression; Glucose; Protein
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2023
    
 
    
        Prepublished in Year
        0
    
 
    
        HGF-reported in Year
        2023
    
 
    
    
        ISSN (print) / ISBN
        1664-2392
    
 
    
        e-ISSN
        1664-2392
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 14,  
	    Issue: ,  
	    Pages: ,  
	    Article Number: 1152444 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Frontiers
        
 
        
            Publishing Place
            Lausanne
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
    
        Institute(s)
        Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
    
 
    
        POF-Topic(s)
        30201 - Metabolic Health
    
 
    
        Research field(s)
        Helmholtz Diabetes Center
    
 
    
        PSP Element(s)
        G-506500-001
G-506501-001
    
 
    
        Grants
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2023-10-06